Weight-loss drugmakers report strong earnings: Boon or bane?
Views 123K
Contents 246
NEWS!
$Astria Therapeutics Inc (ATXS.US)$ Astria Therapeutics Enters Worldwide Exclusive License Agreement With Ichnos Sciences For An OX40 Portfolio; To Pay Ichnos One-time Upfront License Fee Of $15M, Up To $305M In MilestonesMoomoo 24/7· 17 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Trytosaveabit OP : Going on my watch list